Aqr Capital Management LLC Denali Therapeutics Inc. Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 16,018 shares of DNLI stock, worth $382,349. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,018
Holding current value
$382,349
% of portfolio
0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$20.96 - $31.05 $335,737 - $497,358
16,018 New
16,018 $466,000
Q1 2024

May 15, 2024
BUY
$15.83 - $23.35 $174,145 - $256,873
11,001 New
11,001 $225,000
Q2 2023

Aug 14, 2023
SELL
$23.37 - $32.96 $24,211 - $34,146
-1,036 Reduced 11.26%
8,165 $240,000
Q1 2023

May 15, 2023
BUY
$21.91 - $32.67 $201,593 - $300,596
9,201 New
9,201 $211,000
Q2 2022

Aug 15, 2022
SELL
$20.88 - $35.19 $473,683 - $798,320
-22,686 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$29.0 - $47.27 $840,449 - $1.37 Million
-28,981 Reduced 56.09%
22,686 $730,000
Q4 2021

Feb 14, 2022
SELL
$42.59 - $55.02 $1.29 Million - $1.67 Million
-30,382 Reduced 37.03%
51,667 $2.3 Million
Q3 2021

Nov 15, 2021
BUY
$48.48 - $78.23 $134,047 - $216,305
2,765 Added 3.49%
82,049 $4.14 Million
Q2 2021

Aug 16, 2021
SELL
$50.3 - $78.44 $369,202 - $575,749
-7,340 Reduced 8.47%
79,284 $6.22 Million
Q1 2021

May 17, 2021
BUY
$53.8 - $81.53 $1.22 Million - $1.86 Million
22,757 Added 35.63%
86,624 $4.95 Million
Q4 2020

Feb 16, 2021
BUY
$36.89 - $93.56 $465,551 - $1.18 Million
12,620 Added 24.63%
63,867 $5.35 Million
Q3 2020

Nov 16, 2020
BUY
$23.13 - $38.84 $517,418 - $868,850
22,370 Added 77.47%
51,247 $1.84 Million
Q2 2020

Aug 17, 2020
BUY
$16.01 - $28.82 $32,772 - $58,994
2,047 Added 7.63%
28,877 $698,000
Q1 2020

May 15, 2020
SELL
$14.2 - $27.98 $317,725 - $626,052
-22,375 Reduced 45.47%
26,830 $470,000
Q4 2019

Feb 14, 2020
SELL
$14.4 - $19.99 $284,961 - $395,582
-19,789 Reduced 28.68%
49,205 $857,000
Q3 2019

Nov 14, 2019
BUY
$15.32 - $21.92 $898,487 - $1.29 Million
58,648 Added 566.87%
68,994 $1.06 Million
Q2 2019

Aug 14, 2019
BUY
$18.5 - $28.14 $191,401 - $291,136
10,346 New
10,346 $215,000

Others Institutions Holding DNLI

# of Institutions
228
Shares Held
120M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.2B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email